These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 15721360)

  • 1. The N-terminal domain of the vaccinia virus E3L-protein is required for neurovirulence, but not induction of a protective immune response.
    Brandt T; Heck MC; Vijaysri S; Jentarra GM; Cameron JM; Jacobs BL
    Virology; 2005 Mar; 333(2):263-70. PubMed ID: 15721360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagonizing activity of vaccinia virus E3L against human interferons in Huh7 cells.
    Arsenio J; Deschambault Y; Cao J
    Virology; 2008 Jul; 377(1):124-32. PubMed ID: 18502465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modified vaccinia virus Ankara protein F1L is a novel BH3-domain-binding protein and acts together with the early viral protein E3L to block virus-associated apoptosis.
    Fischer SF; Ludwig H; Holzapfel J; Kvansakul M; Chen L; Huang DC; Sutter G; Knese M; Häcker G
    Cell Death Differ; 2006 Jan; 13(1):109-18. PubMed ID: 16003387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenicity and immunogenicity of recombinant Tiantan Vaccinia Virus with deleted C12L and A53R genes.
    Dai K; Liu Y; Liu M; Xu J; Huang W; Huang X; Liu L; Wan Y; Hao Y; Shao Y
    Vaccine; 2008 Sep; 26(39):5062-71. PubMed ID: 18573290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of PKR by vaccinia virus: role of the N- and C-terminal domains of E3L.
    Langland JO; Jacobs BL
    Virology; 2004 Jul; 324(2):419-29. PubMed ID: 15207627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Both carboxy- and amino-terminal domains of the vaccinia virus interferon resistance gene, E3L, are required for pathogenesis in a mouse model.
    Brandt TA; Jacobs BL
    J Virol; 2001 Jan; 75(2):850-6. PubMed ID: 11134298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complementation of vaccinia virus deleted of the E3L gene by mutants of E3L.
    Shors T; Kibler KV; Perkins KB; Seidler-Wulff R; Banaszak MP; Jacobs BL
    Virology; 1997 Dec; 239(2):269-76. PubMed ID: 9434718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccinia viruses with mutations in the E3L gene as potential replication-competent, attenuated vaccines: intra-nasal vaccination.
    Vijaysri S; Jentarra G; Heck MC; Mercer AA; McInnes CJ; Jacobs BL
    Vaccine; 2008 Jan; 26(5):664-76. PubMed ID: 18096276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccinia virus gene B7R encodes an 18-kDa protein that is resident in the endoplasmic reticulum and affects virus virulence.
    Price N; Tscharke DC; Hollinshead M; Smith GL
    Virology; 2000 Feb; 267(1):65-79. PubMed ID: 10648184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccinia virus E3L interferon resistance protein inhibits the interferon-induced adenosine deaminase A-to-I editing activity.
    Liu Y; Wolff KC; Jacobs BL; Samuel CE
    Virology; 2001 Oct; 289(2):378-87. PubMed ID: 11689059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuation of a vaccine strain of vaccinia virus via inactivation of interferon viroceptor.
    Dénes B; Gridley DS; Fodor N; Takátsy Z; Timiryasova TM; Fodor I
    J Gene Med; 2006 Jul; 8(7):814-23. PubMed ID: 16634110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization with influenza A NP-expressing vaccinia virus recombinant protects mice against experimental infection with human and avian influenza viruses.
    Altstein AD; Gitelman AK; Smirnov YA; Piskareva LM; Zakharova LG; Pashvykina GV; Shmarov MM; Zhirnov OP; Varich NP; Ilyinskii PO; Shneider AM
    Arch Virol; 2006 May; 151(5):921-31. PubMed ID: 16292596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The vaccinia virus A38L gene product is a 33-kDa integral membrane glycoprotein.
    Parkinson JE; Sanderson CM; Smith GL
    Virology; 1995 Dec; 214(1):177-88. PubMed ID: 8525613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. siRNA targeting vaccinia virus double-stranded RNA binding protein [E3L] exerts potent antiviral effects.
    Dave RS; McGettigan JP; Qureshi T; Schnell MJ; Nunnari G; Pomerantz RJ
    Virology; 2006 May; 348(2):489-97. PubMed ID: 16480752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenicity and immunogenicity in mice of vaccinia viruses mutated in the viral envelope proteins A33R and B5R.
    Gurt I; Abdalrhman I; Katz E
    Antiviral Res; 2006 Mar; 69(3):158-64. PubMed ID: 16406098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reintroduction of gene(s) into an attenuated deletion mutant of vaccinia virus strain IHD-W.
    Chang PY; Pogo BG
    Microb Pathog; 1993 Nov; 15(5):347-57. PubMed ID: 8015416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of interferon induction and action by the E3L double-stranded RNA binding proteins of vaccinia virus.
    Xiang Y; Condit RC; Vijaysri S; Jacobs B; Williams BR; Silverman RH
    J Virol; 2002 May; 76(10):5251-9. PubMed ID: 11967338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Orf virus E3L homologue is able to complement deletion of the vaccinia virus E3L gene in vitro but not in vivo.
    Vijaysri S; Talasela L; Mercer AA; Mcinnes CJ; Jacobs BL; Langland JO
    Virology; 2003 Sep; 314(1):305-14. PubMed ID: 14517083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evasion of the Innate Immune Type I Interferon System by Monkeypox Virus.
    Arndt WD; Cotsmire S; Trainor K; Harrington H; Hauns K; Kibler KV; Huynh TP; Jacobs BL
    J Virol; 2015 Oct; 89(20):10489-99. PubMed ID: 26246580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Host range, growth property, and virulence of the smallpox vaccine: vaccinia virus Tian Tan strain.
    Fang Q; Yang L; Zhu W; Liu L; Wang H; Yu W; Xiao G; Tien P; Zhang L; Chen Z
    Virology; 2005 May; 335(2):242-51. PubMed ID: 15840523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.